Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre

In order to assess the efficacy of modern antiepileptic drug (AED) therapy, we collected data from 517 consecutive adult outpatients referred to our centre between March and August 2011. In total, 211 patients (40.8%) were treated with monotherapy, 208 patients (40.2%) with a combination of two AEDs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Epileptic disorders 2012-12, Vol.14 (4), p.379-387
Hauptverfasser: Steinhoff, Bernhard J., Staack, Anke Maren, Wisniewski, Ilona
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 387
container_issue 4
container_start_page 379
container_title Epileptic disorders
container_volume 14
creator Steinhoff, Bernhard J.
Staack, Anke Maren
Wisniewski, Ilona
description In order to assess the efficacy of modern antiepileptic drug (AED) therapy, we collected data from 517 consecutive adult outpatients referred to our centre between March and August 2011. In total, 211 patients (40.8%) were treated with monotherapy, 208 patients (40.2%) with a combination of two AEDs, and for the remaining patients ( n =98; 19%) more than two AEDs were combined. The most common AEDs were valproate, lamotrigine, carbamazepine, and levetiracetam. Of the recent AEDs, levetiracetamwas the leading drug with regards to drug combinations. Freedom of seizures for more than one year was achieved in 291 patients (56.3%). Under monotherapy, 168 patients (32.5% of all patients; 79.6% of patients with monotherapy) became seizure-free. Seizure-freedom with two AEDs was achieved in 103 patients (19.9% of all patients; 49.5% of patients with two AEDs) and in 20 patients with three AEDs (3.9% of all patients; 25.3% of patients with three AEDs). We conclude from this cross-sectional survey in a large patient group that combinations may still lead to treatment success in a considerable proportion of patients.
doi_str_mv 10.1684/epd.2012.0544
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1273112800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1273112800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-7c4e44ffe23c3d22e7cf245bd22ca1f9a3ea5e049f71ec2d8959207d7cde51fb3</originalsourceid><addsrcrecordid>eNpt0TlPwzAUB3ALgWg5RlZkiYUlxXacuhlRVQ5RiQGYLdd5aV3SJPgAlU-PQ8shxOQnv5__tvwQOqFkQIcjfgFtMWCEsgHJON9BfZpnJBnmPNv9VffQgXNLQljcoPuox1ImOB2yPmofwLwHC1g3tbdNhd-MX2BVewOtqaD1RuPChjn2C7CqXWNT44yKjjvQwZtXwKoIlcdN8K2Kx2rvsPKdx3eNfcaTzxy3xuPYsnCE9kpVOTjerofo6WryOL5JpvfXt-PLaaLTIfGJ0Bw4L0tgqU4LxkDokvFsFkutaJmrFFQGhOeloKBZMcqznBFRCF1ARstZeojON7mtbV4COC9XxmmoKlVDE5ykTKSUshEhkZ79ocsm2Dq-TrKRSImIrlPJRmnbOGehlK01K2XXkhLZjULGUchuFLIbRfSn29QwW0Hxrb_-PoLBBrjYqudgf679P_ED0OaU2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2873071120</pqid></control><display><type>article</type><title>Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>John Libbey Eurotext Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Steinhoff, Bernhard J. ; Staack, Anke Maren ; Wisniewski, Ilona</creator><creatorcontrib>Steinhoff, Bernhard J. ; Staack, Anke Maren ; Wisniewski, Ilona</creatorcontrib><description>In order to assess the efficacy of modern antiepileptic drug (AED) therapy, we collected data from 517 consecutive adult outpatients referred to our centre between March and August 2011. In total, 211 patients (40.8%) were treated with monotherapy, 208 patients (40.2%) with a combination of two AEDs, and for the remaining patients ( n =98; 19%) more than two AEDs were combined. The most common AEDs were valproate, lamotrigine, carbamazepine, and levetiracetam. Of the recent AEDs, levetiracetamwas the leading drug with regards to drug combinations. Freedom of seizures for more than one year was achieved in 291 patients (56.3%). Under monotherapy, 168 patients (32.5% of all patients; 79.6% of patients with monotherapy) became seizure-free. Seizure-freedom with two AEDs was achieved in 103 patients (19.9% of all patients; 49.5% of patients with two AEDs) and in 20 patients with three AEDs (3.9% of all patients; 25.3% of patients with three AEDs). We conclude from this cross-sectional survey in a large patient group that combinations may still lead to treatment success in a considerable proportion of patients.</description><identifier>ISSN: 1950-6945</identifier><identifier>ISSN: 1294-9361</identifier><identifier>EISSN: 1950-6945</identifier><identifier>DOI: 10.1684/epd.2012.0544</identifier><identifier>PMID: 23274162</identifier><language>eng</language><publisher>Paris: John Libbey Eurotext</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Ambulatory Care ; Anticonvulsants - therapeutic use ; Antiepileptic agents ; Carbamazepine ; Carbamazepine - therapeutic use ; Convulsions &amp; seizures ; Cross-Sectional Studies ; Drug therapy ; Drug Therapy, Combination - methods ; Epilepsy ; Epilepsy - drug therapy ; Etiracetam ; Female ; Humans ; Lamotrigine ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Neurobiology ; Neurology ; Neuropsychology ; Neuroradiology ; Original Article ; Piracetam - analogs &amp; derivatives ; Piracetam - therapeutic use ; Seizures ; Treatment Outcome ; Triazines - therapeutic use ; Valproic acid ; Valproic Acid - therapeutic use ; Young Adult</subject><ispartof>Epileptic disorders, 2012-12, Vol.14 (4), p.379-387</ispartof><rights>John Libbey Eurotext and Springer-Verlag France 2012</rights><rights>International League Against Epilepsy</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-7c4e44ffe23c3d22e7cf245bd22ca1f9a3ea5e049f71ec2d8959207d7cde51fb3</citedby><cites>FETCH-LOGICAL-c360t-7c4e44ffe23c3d22e7cf245bd22ca1f9a3ea5e049f71ec2d8959207d7cde51fb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23274162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Steinhoff, Bernhard J.</creatorcontrib><creatorcontrib>Staack, Anke Maren</creatorcontrib><creatorcontrib>Wisniewski, Ilona</creatorcontrib><title>Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre</title><title>Epileptic disorders</title><addtitle>Epileptic Disord</addtitle><addtitle>Epileptic Disord</addtitle><description>In order to assess the efficacy of modern antiepileptic drug (AED) therapy, we collected data from 517 consecutive adult outpatients referred to our centre between March and August 2011. In total, 211 patients (40.8%) were treated with monotherapy, 208 patients (40.2%) with a combination of two AEDs, and for the remaining patients ( n =98; 19%) more than two AEDs were combined. The most common AEDs were valproate, lamotrigine, carbamazepine, and levetiracetam. Of the recent AEDs, levetiracetamwas the leading drug with regards to drug combinations. Freedom of seizures for more than one year was achieved in 291 patients (56.3%). Under monotherapy, 168 patients (32.5% of all patients; 79.6% of patients with monotherapy) became seizure-free. Seizure-freedom with two AEDs was achieved in 103 patients (19.9% of all patients; 49.5% of patients with two AEDs) and in 20 patients with three AEDs (3.9% of all patients; 25.3% of patients with three AEDs). We conclude from this cross-sectional survey in a large patient group that combinations may still lead to treatment success in a considerable proportion of patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Ambulatory Care</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Antiepileptic agents</subject><subject>Carbamazepine</subject><subject>Carbamazepine - therapeutic use</subject><subject>Convulsions &amp; seizures</subject><subject>Cross-Sectional Studies</subject><subject>Drug therapy</subject><subject>Drug Therapy, Combination - methods</subject><subject>Epilepsy</subject><subject>Epilepsy - drug therapy</subject><subject>Etiracetam</subject><subject>Female</subject><subject>Humans</subject><subject>Lamotrigine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Neurobiology</subject><subject>Neurology</subject><subject>Neuropsychology</subject><subject>Neuroradiology</subject><subject>Original Article</subject><subject>Piracetam - analogs &amp; derivatives</subject><subject>Piracetam - therapeutic use</subject><subject>Seizures</subject><subject>Treatment Outcome</subject><subject>Triazines - therapeutic use</subject><subject>Valproic acid</subject><subject>Valproic Acid - therapeutic use</subject><subject>Young Adult</subject><issn>1950-6945</issn><issn>1294-9361</issn><issn>1950-6945</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0TlPwzAUB3ALgWg5RlZkiYUlxXacuhlRVQ5RiQGYLdd5aV3SJPgAlU-PQ8shxOQnv5__tvwQOqFkQIcjfgFtMWCEsgHJON9BfZpnJBnmPNv9VffQgXNLQljcoPuox1ImOB2yPmofwLwHC1g3tbdNhd-MX2BVewOtqaD1RuPChjn2C7CqXWNT44yKjjvQwZtXwKoIlcdN8K2Kx2rvsPKdx3eNfcaTzxy3xuPYsnCE9kpVOTjerofo6WryOL5JpvfXt-PLaaLTIfGJ0Bw4L0tgqU4LxkDokvFsFkutaJmrFFQGhOeloKBZMcqznBFRCF1ARstZeojON7mtbV4COC9XxmmoKlVDE5ykTKSUshEhkZ79ocsm2Dq-TrKRSImIrlPJRmnbOGehlK01K2XXkhLZjULGUchuFLIbRfSn29QwW0Hxrb_-PoLBBrjYqudgf679P_ED0OaU2A</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>Steinhoff, Bernhard J.</creator><creator>Staack, Anke Maren</creator><creator>Wisniewski, Ilona</creator><general>John Libbey Eurotext</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20121201</creationdate><title>Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre</title><author>Steinhoff, Bernhard J. ; Staack, Anke Maren ; Wisniewski, Ilona</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-7c4e44ffe23c3d22e7cf245bd22ca1f9a3ea5e049f71ec2d8959207d7cde51fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Ambulatory Care</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Antiepileptic agents</topic><topic>Carbamazepine</topic><topic>Carbamazepine - therapeutic use</topic><topic>Convulsions &amp; seizures</topic><topic>Cross-Sectional Studies</topic><topic>Drug therapy</topic><topic>Drug Therapy, Combination - methods</topic><topic>Epilepsy</topic><topic>Epilepsy - drug therapy</topic><topic>Etiracetam</topic><topic>Female</topic><topic>Humans</topic><topic>Lamotrigine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Neurobiology</topic><topic>Neurology</topic><topic>Neuropsychology</topic><topic>Neuroradiology</topic><topic>Original Article</topic><topic>Piracetam - analogs &amp; derivatives</topic><topic>Piracetam - therapeutic use</topic><topic>Seizures</topic><topic>Treatment Outcome</topic><topic>Triazines - therapeutic use</topic><topic>Valproic acid</topic><topic>Valproic Acid - therapeutic use</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Steinhoff, Bernhard J.</creatorcontrib><creatorcontrib>Staack, Anke Maren</creatorcontrib><creatorcontrib>Wisniewski, Ilona</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Epileptic disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Steinhoff, Bernhard J.</au><au>Staack, Anke Maren</au><au>Wisniewski, Ilona</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre</atitle><jtitle>Epileptic disorders</jtitle><stitle>Epileptic Disord</stitle><addtitle>Epileptic Disord</addtitle><date>2012-12-01</date><risdate>2012</risdate><volume>14</volume><issue>4</issue><spage>379</spage><epage>387</epage><pages>379-387</pages><issn>1950-6945</issn><issn>1294-9361</issn><eissn>1950-6945</eissn><abstract>In order to assess the efficacy of modern antiepileptic drug (AED) therapy, we collected data from 517 consecutive adult outpatients referred to our centre between March and August 2011. In total, 211 patients (40.8%) were treated with monotherapy, 208 patients (40.2%) with a combination of two AEDs, and for the remaining patients ( n =98; 19%) more than two AEDs were combined. The most common AEDs were valproate, lamotrigine, carbamazepine, and levetiracetam. Of the recent AEDs, levetiracetamwas the leading drug with regards to drug combinations. Freedom of seizures for more than one year was achieved in 291 patients (56.3%). Under monotherapy, 168 patients (32.5% of all patients; 79.6% of patients with monotherapy) became seizure-free. Seizure-freedom with two AEDs was achieved in 103 patients (19.9% of all patients; 49.5% of patients with two AEDs) and in 20 patients with three AEDs (3.9% of all patients; 25.3% of patients with three AEDs). We conclude from this cross-sectional survey in a large patient group that combinations may still lead to treatment success in a considerable proportion of patients.</abstract><cop>Paris</cop><pub>John Libbey Eurotext</pub><pmid>23274162</pmid><doi>10.1684/epd.2012.0544</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1950-6945
ispartof Epileptic disorders, 2012-12, Vol.14 (4), p.379-387
issn 1950-6945
1294-9361
1950-6945
language eng
recordid cdi_proquest_miscellaneous_1273112800
source MEDLINE; Wiley Online Library Journals Frontfile Complete; John Libbey Eurotext Journals; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Adult
Aged
Aged, 80 and over
Ambulatory Care
Anticonvulsants - therapeutic use
Antiepileptic agents
Carbamazepine
Carbamazepine - therapeutic use
Convulsions & seizures
Cross-Sectional Studies
Drug therapy
Drug Therapy, Combination - methods
Epilepsy
Epilepsy - drug therapy
Etiracetam
Female
Humans
Lamotrigine
Male
Medicine
Medicine & Public Health
Middle Aged
Neurobiology
Neurology
Neuropsychology
Neuroradiology
Original Article
Piracetam - analogs & derivatives
Piracetam - therapeutic use
Seizures
Treatment Outcome
Triazines - therapeutic use
Valproic acid
Valproic Acid - therapeutic use
Young Adult
title Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T20%3A44%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seizure%20control%20with%20antiepileptic%20drug%20therapy%20in%20517%20consecutive%20adult%20outpatients%20at%20the%20Kork%20Epilepsy%20Centre&rft.jtitle=Epileptic%20disorders&rft.au=Steinhoff,%20Bernhard%20J.&rft.date=2012-12-01&rft.volume=14&rft.issue=4&rft.spage=379&rft.epage=387&rft.pages=379-387&rft.issn=1950-6945&rft.eissn=1950-6945&rft_id=info:doi/10.1684/epd.2012.0544&rft_dat=%3Cproquest_cross%3E1273112800%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2873071120&rft_id=info:pmid/23274162&rfr_iscdi=true